A Breine, K Van Holsbeeck, C Martin… - Bioconjugate …, 2023 - ACS Publications
Membrane interaction constitutes to be an essential parameter in the mode of action of entities such as proteins, as well as cell-penetrating and antimicrobial peptides, resulting in …
A Valcek, C Philippe, C Whiteway, E Robino… - Microbiology …, 2023 - Am Soc Microbiol
Acinetobacter baumannii is an opportunistic pathogenic bacterium prioritized by WHO and CDC because of its increasing antibiotic resistance. Heterogeneity among strains represents …
Acinetobacter baumannii forms air–liquid interface pellicles that boost its ability to withstand desiccation and increase survival under antibiotic pressure. This study aims to delve into the …
C Philippe, A Valcek, C Whiteway, E Robino… - bioRxiv, 2022 - biorxiv.org
We assembled the whole genome sequence (WGS) of a collection of 43 non-redundant modern clinical isolates and four broadly used reference strains of Acinetobacter baumannii …
M Koncz, T Stirling, H Hadj Mehdi, O Méhi, B Eszenyi… - bioRxiv, 2024 - biorxiv.org
Phage therapy is gaining increasing interest in the fight against critically resistant nosocomial pathogens. However, the narrow host range of bacteriophages hampers the …
K Javadi - Avicenna Journal of Clinical Microbiology and Infection, 2024 - ajcmi.umsha.ac.ir
Acinetobacter baumannii is a significant cause of healthcare-associated infections, particularly in intensive care units, where its ability to develop multidrug resistance …
Acinetobacter baumannii, is a gram-negative opportunistic pathogennotorious for its antibiotic resistance and adaptability. These attributes present significant challenges in …
Phage therapy is gaining increasing interest in the fight against critically antibiotic-resistant nosocomial pathogens. However, the narrow host range of bacteriophages hampers the …